Consolidated Statements of Income - USD ($)	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Net revenues	$ 3,018,954	$ 3,754,212
Cost of sales	1,454,700	1,865,908
Gross Profit	1,564,254	1,888,304
Operating expenses:
Research and development	673,855	527,659
Selling, general and administrative	1,243,011	1,404,604
Depreciation and amortization	22,108	22,229
Total operating expenses	1,938,974	1,954,492
Income (loss) from operations	(374,720)	(66,188)
Other income (expense):
Interest income	26,948	17,632
Interest expense	(8,807)	(6,707)
Total other income (expense)	18,141	10,925
Income (loss) before provision for taxes	(356,579)	(55,263)
Provision (benefit) for income taxes:
Current	1,000	(1,000)
Deferred	(15,000)	166,000
Total benefit (provision) for income taxes	(14,000)	165,000
Net income (loss)	$ (342,579)	$ 109,737
Basic and diluted earnings per common share: (in dollars per share)	$ (0.01)	$ 0
Weighted average shares of common stock outstanding - basic (in shares)	67,588,492	67,588,492
Weighted average shares of common stock outstanding - diluted (in shares)	67,588,492	67,588,492